Back
BioXcel Therapeutics Stock Price Chart
Mode Mobile Could be Next in Line
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23
BTAI
BioXcel Therapeutics
Last Price:
$1.75
Seasonality Move:
4.9%
7 Day Trial
ALL ACCESS PASS
$
7
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing selling pressure, which indicates risk of future bearish movement.
BioXcel Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.75 | Sell |
| 20-day SMA: | 1.92 | Sell |
| 50-day SMA: | 2.25 | Sell |
| 200-day SMA: | 8.11 | Sell |
| 8-day EMA: | 1.79 | Sell |
| 20-day EMA: | 1.94 | Sell |
| 50-day EMA: | 2.69 | Sell |
| 200-day EMA: | 14.08 | Sell |
BioXcel Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 41.65 | Sell |
| Chaikin Money Flow: | -50204 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.72 - 2.26) | Sell |
| Bollinger Bands (100): | (2.1 - 6.38) | Sell |
BioXcel Therapeutics Technical Analysis
| Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BioXcel Therapeutics Stock
Is BioXcel Therapeutics Stock a Buy?
-
BioXcel Therapeutics share price is 1.74 while BTAI 8-day simple moving average is 1.75, which is a Sell signal.
-
The stock price of BTAI is 1.74 while BioXcel Therapeutics 20-day SMA is 1.92, which makes it a Sell.
-
BioXcel Therapeutics 50-day simple moving average is 2.25 while BTAI share price is 1.74, making it a Sell technically.
-
BTAI stock price is 1.74 and BioXcel Therapeutics 200-day simple moving average is 8.11, creating a Sell signal.
BTAI Technical Analysis vs Fundamental Analysis
Sell
23
BioXcel Therapeutics (BTAI)
is a Sell
Is BioXcel Therapeutics a Buy or a Sell?
-
BioXcel Therapeutics stock is rated a SellThe current BioXcel Therapeutics [BTAI] share price is $1.74. The Score for BTAI is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
BioXcel Therapeutics Stock Info
Market Cap:
9.5M
Price in USD:
1.74
Share Volume:
90.2K
BioXcel Therapeutics 52-Week Range
52-Week High:
48.72
52-Week Low:
1.29
Sell
23
BioXcel Therapeutics (BTAI)
is a Sell
BioXcel Therapeutics Share Price Forecast
-
What is the BioXcel Therapeutics stock price today?The BioXcel Therapeutics stock price is 1.74 USD today.
-
Will BTAI stock go up or go down?BioXcel Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is BioXcel Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioXcel Therapeutics is overvalued.
Is BioXcel Therapeutics Stock a Buy?
-
BioXcel Therapeutics share price is 1.74 while BTAI 8-day exponential moving average is 1.79, which is a Sell signal.
-
The stock price of BTAI is 1.74 while BioXcel Therapeutics 20-day EMA is 1.94, which makes it a Sell.
-
BioXcel Therapeutics 50-day exponential moving average is 2.69 while BTAI share price is 1.74, making it a Sell technically.
-
BTAI stock price is 1.74 and BioXcel Therapeutics 200-day simple moving average is 14.08, creating a Sell signal.
Fundamental Analysis of BioXcel Therapeutics
Is BioXcel Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $5.84 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.06 per share, and an increase next year of $7.39 per share.
Technical Analysis of BioXcel Therapeutics
Should I short BioXcel Therapeutics stock?
-
BTAI Moving Average Covergence Divergence (MACD) indicator is -0.22, suggesting BioXcel Therapeutics is a Sell
-
BioXcel Therapeutics Relative Strength Index (RSI) is 41.65, which suggest BioXcel Therapeutics is oversold
-
The Bollinger Bands (25) for BioXcel Therapeutics is (1.72 - 2.26), which suggest BioXcel Therapeutics is a Sell
-
The Bollinger Bands (100) for BioXcel Therapeutics is (2.1 - 6.38), which suggest BioXcel Therapeutics is a Sell
* BioXcel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.